These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37510717)

  • 1. Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study.
    Bundó D; Cunillera O; Arbiol-Roca A; Cobo-Guerrero S; Romano J; Gil-Terron N; Fulladosa X; Comas J; Rama I; Cruzado JM; Salvador-Gonzalez B
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD.
    Thanabalasingam SJ; Iliescu EA; Norman PA; Day AG; Akbari A; Hundemer GL; White CA
    Kidney Med; 2022 Apr; 4(4):100440. PubMed ID: 35445190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding International Variations in Kidney Failure Incidence and Initiation of Replacement Therapy.
    Alencar de Pinho N; Henn L; Raina R; Reichel H; Lopes AA; Combe C; Speyer E; Bieber B; Robinson BM; Stengel B; Pecoits-Filho R;
    Kidney Int Rep; 2022 Nov; 7(11):2364-2375. PubMed ID: 36531894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factor for progression to kidney failure with replacement therapy in elderly patients with chronic kidney disease: A retrospective single-centre cohort study.
    Nagae H; Ueno Y; Shojima M; Takae K; Kuroki Y; Katafuchi R
    Nephrology (Carlton); 2023 Jun; 28(6):336-344. PubMed ID: 37086149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.
    Hsu CM; Gupta S; Tighiouart H; Goyal N; Faugno AJ; Tariq A; Raichoudhury R; Sharma JH; Meyer L; Kshirsagar RK; Jose A; Leaf DE; Weiner DE;
    Am J Kidney Dis; 2022 Mar; 79(3):404-416.e1. PubMed ID: 34871701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Mehta R; Cai X; Lee J; Xie D; Wang X; Scialla J; Anderson AH; Taliercio J; Dobre M; Chen J; Fischer M; Leonard M; Lash J; Hsu CY; de Boer IH; Feldman HI; Wolf M; Isakova T;
    Am J Kidney Dis; 2020 Jun; 75(6):908-918. PubMed ID: 31864822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic Blood Pressure and the Risk of Kidney Replacement Therapy and Mortality in Patients with Chronic Kidney Disease Stages 4-5.
    Chávez-Iñiguez JS; Zaragoza JJ; Camacho-Guerrero JR; Villavicencio-Cerón V; Valdez-Ortiz R; Huerta-Orozco AE; Chávez-Alonso G; Oliva-Martinez AE; Díaz-Villavicencio B; Calderón-García CE; González-Barajas JD; Arizaga-Nápoles M; De La Vega-Méndez FM; Gómez-Fregoso JA; Rodríguez-García FG; Navarro-Blackaller G; Medina-González R; Alcantar-Vallin L; García-García G
    Kidney Blood Press Res; 2023; 48(1):556-567. PubMed ID: 37544290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease in public renal practices in Queensland, Australia, 2011-2018.
    Hoy WE; Wang Z; Zhang J; Diwan V; Cameron A; Venuthurupalli SK; Fassett RG; Chan S; Healy HG; Tan KS; Baer R; Mallett AJ; Gray N; Mantha M; Cherian R; Mutatiri C; Madhan K; Kan G; Mitchell G; Hossain S; Wu D; Han T; Kark A; Titus T; Ranganathan D; Bonner A; Govindarajulu S;
    Nephrology (Carlton); 2022 Dec; 27(12):934-944. PubMed ID: 36161428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death and Dialysis Following Discharge From Chronic Kidney Disease Clinic: A Retrospective Cohort Study.
    Che M; Iliescu E; Thanabalasingam S; Day AG; White CA
    Can J Kidney Health Dis; 2022; 9():20543581221118434. PubMed ID: 35992302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy.
    Ortiz A
    Clin Kidney J; 2022 Jul; 15(7):1221-1225. PubMed ID: 35756737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain management and the use of opioids in adults with kidney failure receiving conservative kidney management.
    Davison SN; Wearne N; Bagasha P; Krause R
    Ann Palliat Med; 2024 Mar; 13(2):334-343. PubMed ID: 38373779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls.
    van Oosten MJM; Logtenberg SJJ; Hemmelder MH; Leegte MJH; Bilo HJG; Jager KJ; Stel VS
    Clin Kidney J; 2021 Dec; 14(12):2497-2523. PubMed ID: 34950462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Chen S; Chen L; Jiang H
    Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Risk and Mortality in Patients With Kidney Disease: A Population-Based Cohort Study.
    Kitchlu A; Reid J; Jeyakumar N; Dixon SN; Munoz AM; Silver SA; Booth CM; Chan CTM; Garg AX; Amir E; Kim SJ; Wald R
    Am J Kidney Dis; 2022 Oct; 80(4):436-448.e1. PubMed ID: 35405208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Consequences of Acute Kidney Injury in Patients With CKD: A Registry Study in Queensland Australia.
    Zhang J; Healy HG; Baboolal K; Wang Z; Venuthurupalli SK; Tan KS; Cameron A; Hoy WE;
    Kidney Med; 2019; 1(4):180-190. PubMed ID: 32734198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults.
    Chang TI; Lim H; Park CH; Rhee CM; Moradi H; Kalantar-Zadeh K; Kang EW; Kang SW; Han SH
    Am J Kidney Dis; 2020 Aug; 76(2):224-232. PubMed ID: 32305207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.